Sun Pharmaceutical Industries Limited — Updates, 27-04-2026: General Updates

Sun Pharma is acquiring Organon for US$ 11.75 billion enterprise value in an all-cash deal. This strengthens its women's health, biosimilars, and established brands portfolio, targeting US$ 12.4 billion combined revenue and enhanced cash flow.